Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Genotype × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4 Pancreatic Neoplasms 2 Thyroid Cancer, Papillary 1 Myasthenia Gravis 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Glioblastoma 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1

Interventions

aldesleukin 39 Sunitinib 36 Cyclophosphamide 29 Nivolumab 28 pembrolizumab 26 Interferon-alpha 25 Everolimus 24 Sorafenib 21 Bevacizumab 20 fludarabine phosphate 19 Ipilimumab 17 Interleukin-2 17 Radiotherapy 16 Peripheral Blood Stem Cell Transplantation 15 Gene Expression Profiling 15 Gemcitabine 15 Filgrastim 15 Axitinib 15 cabozantinib 13 Radiosurgery 12 Blood Specimen Collection 11 temsirolimus 10 fludarabine 10 Doxorubicin 10 Carboplatin 10 sargramostim 8 belzutifan 8 Immunohistochemistry 8 Fluorouracil 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02404584 2025-12-04

GenCInibs-Suni

Centre Hospitalier Universitaire de Nīmes

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡